Alberto Langtry is a Postdoctoral Research Scientist in Columbia University’s Systems Biology department, where he applies his expertise as a Computational Biologist to immuno-oncology research. His research is focused on exploring the role of MHC as a prognostic marker for across various cancer types, employing multi-omics data integration and advanced bioinformatics methodologies. His work aims to identify novel biomarkers and therapeutic targets to enhance clinical management strategies and improve the efficacy of immunotherapies and other cancer treatments.